{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:58:05Z","timestamp":1790805485458,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000770","name":"University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003061","name":"Erasmus MC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009480","name":"Erasmus MC Sophia Foundation","doi-asserted-by":"publisher","award":["B17-04"],"award-info":[{"award-number":["B17-04"]}],"id":[{"id":"10.13039\/501100009480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003192","name":"Neurofibromatosis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacapopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAACAP Open"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaacop.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:28:48Z","timestamp":1782869328000},"page":"768-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relation Between Genotype and Behavioral Phenotype in Children and Adolescents With Neurofibromatosis Type 1"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1934-7752","authenticated-orcid":false,"given":"Myrthe J.","family":"Ottenhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-0836","authenticated-orcid":false,"given":"Andre B.","family":"Rietman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-9012","authenticated-orcid":false,"given":"Daniela","family":"Gawehns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0949-1566","authenticated-orcid":false,"given":"Mark","family":"Nellist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"O\u2019Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Kimber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma M.M.","family":"Burkitt Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5918-3220","authenticated-orcid":false,"given":"Caroline","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6478-181X","authenticated-orcid":false,"given":"Ellen","family":"Denayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-8934","authenticated-orcid":false,"given":"Rianne","family":"Oostenbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6306-1981","authenticated-orcid":false,"given":"Pieter F.A.","family":"de Nijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3122-7713","authenticated-orcid":false,"given":"Leontine W.","family":"ten Hoopen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9042-4813","authenticated-orcid":false,"given":"Marie-Claire Y.","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2770-2646","authenticated-orcid":false,"given":"Rick","family":"van Minkelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9304-3322","authenticated-orcid":false,"given":"Henriette A.","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3758-1297","authenticated-orcid":false,"given":"Ype","family":"Elgersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-5606","authenticated-orcid":false,"given":"Gwendolyn C.","family":"Dieleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9088-8095","authenticated-orcid":false,"given":"Sabine E.","family":"Mous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaacop.2026.06.008_bib1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/aur.2864","article-title":"Autism-related language preferences of English-speaking individuals across the globe: a mixed methods investigation","volume":"16","author":"Keating","year":"2023","journal-title":"Autism Res"},{"issue":"03","key":"10.1016\/j.jaacop.2026.06.008_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1469-8749.2002.tb00780.x","article-title":"Treatment of ADHD in neurofibromatosis type 1","volume":"44","author":"Mautner","year":"2002","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"10.1016\/j.jaacop.2026.06.008_bib3","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jaacop.2026.06.008_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaac.2024.09.011","article-title":"Systematic review and meta-analysis: attention-deficit\/hyperactivity disorder symptoms in children with neurofibromatosis type 1","volume":"64","author":"Hou","year":"2024","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"10.1016\/j.jaacop.2026.06.008_bib5","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s10803-018-3478-0","article-title":"Autism spectrum disorder in an unselected cohort of children with neurofibromatosis type 1 (NF1)","volume":"48","author":"Eijk","year":"2018","journal-title":"J Autism Dev Disord"},{"issue":"12","key":"10.1016\/j.jaacop.2026.06.008_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamapsychiatry.2016.2600","article-title":"Disease burden and symptom structure of autism in neurofibromatosis type 1: a study of the International NF1-ASD Consortium Team (INFACT)","volume":"73","author":"Morris","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.jaacop.2026.06.008_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jpeds.2015.04.075","article-title":"Distribution and within-family specificity of quantitative autistic traits in patients with neurofibromatosis type 1","volume":"167","author":"Constantino","year":"2015","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jaacop.2026.06.008_bib8","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/jid.2014.465","article-title":"Incidence and mortality of neurofibromatosis: a total population study in Finland","volume":"135","author":"Uusitalo","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaacop.2026.06.008_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0959-437X(95)90053-5","article-title":"Ras signaling and NF1","volume":"5","author":"McCormick","year":"1995","journal-title":"Curr Opin Genet Dev"},{"issue":"5","key":"10.1016\/j.jaacop.2026.06.008_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41436-020-0752-2","article-title":"Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1","volume":"22","author":"Ottenhoff","year":"2020","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.jaacop.2026.06.008_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1469-8749.2012.04399.x","article-title":"Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence","volume":"55","author":"Lehtonen","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.jaacop.2026.06.008_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2788.2005.00660.x","article-title":"Behavioural, academic and neuropsychological profile of normally gifted neurofibromatosis type 1 children","volume":"49","author":"Descheemaeker","year":"2005","journal-title":"J Intellect Disabil Res"},{"issue":"9","key":"10.1016\/j.jaacop.2026.06.008_bib13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/0883073808316366","article-title":"Impact of neurofibromatosis type 1 on school performance","volume":"23","author":"Krab","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jaacop.2026.06.008_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00415-012-6620-5","article-title":"Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials","volume":"260","author":"Payne","year":"2013","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.jaacop.2026.06.008_bib15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/dmcn.12361","article-title":"Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1","volume":"56","author":"Champion","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"15","key":"10.1016\/j.jaacop.2026.06.008_bib16","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/ddp212","article-title":"Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1","volume":"18","author":"Sabbagh","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.jaacop.2026.06.008_bib17","first-page":"305","article-title":"An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes","volume":"53","author":"Easton","year":"1993","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.jaacop.2026.06.008_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/1479-7364-5-6-623","article-title":"Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis","volume":"5","author":"Laycock-Van Spyk","year":"2011","journal-title":"Hum Genom"},{"issue":"11","key":"10.1016\/j.jaacop.2026.06.008_bib19","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation","volume":"36","author":"Rojnueangnit","year":"2015","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.jaacop.2026.06.008_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","article-title":"Emerging genotype\u2013phenotype relationships in patients with large NF1 deletions","volume":"136","author":"Kehrer-Sawatzki","year":"2017","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.jaacop.2026.06.008_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","article-title":"Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844\u2013848","volume":"102","author":"Koczkowska","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.jaacop.2026.06.008_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41436-018-0269-0","article-title":"Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation","volume":"21","author":"Koczkowska","year":"2019","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.jaacop.2026.06.008_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jaacop.2026.06.008_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/humu.23929","article-title":"Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1","volume":"41","author":"Koczkowska","year":"2020","journal-title":"Hum Mutat"},{"issue":"8","key":"10.1016\/j.jaacop.2026.06.008_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1212\/WNL.0000000000005000","article-title":"A genotype-phenotype correlation for quantitative autistic trait burden in neurofibromatosis 1","volume":"90","author":"Morris","year":"2018","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jaacop.2026.06.008_bib26","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/brain\/awae125","article-title":"Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders","volume":"147","author":"Berg","year":"2024","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jaacop.2026.06.008_bib27","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajhg.2021.01.007","article-title":"Mutation-specific pathophysiological mechanisms define different neurodevelopmental disorders associated with SATB1 dysfunction","volume":"108","author":"Hoed J den","year":"2021","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/j.jaacop.2026.06.008_bib28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ajhg.2022.05.011","article-title":"Rare genetic variants in genes and loci linked to dominant monogenic developmental disorders cause milder related phenotypes in the general population","volume":"109","author":"Kingdom","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.jaacop.2026.06.008_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"Neurofibromatosis. Conference statement","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaacop.2026.06.008_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.852208","article-title":"Autism symptoms in children and young adults with fragile X syndrome, Angelman syndrome, tuberous sclerosis complex, and neurofibromatosis type 1: a cross-syndrome comparison","volume":"13","author":"Lubbers","year":"2022","journal-title":"Front Psychiatry"},{"issue":"2","key":"10.1016\/j.jaacop.2026.06.008_bib31","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10803-024-06557-2","article-title":"Autism spectrum disorder symptom profiles in fragile X syndrome, Angelman syndrome, tuberous sclerosis complex and neurofibromatosis type 1","volume":"56","author":"Lubbers","year":"2026","journal-title":"J Autism Dev Disord"},{"issue":"3","key":"10.1016\/j.jaacop.2026.06.008_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajmg.b.32612","article-title":"Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1","volume":"177","author":"Rietman","year":"2018","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"6","key":"10.1016\/j.jaacop.2026.06.008_bib33","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","article-title":"Neurofibromatosis type 1 and autism spectrum disorder","volume":"132","author":"Garg","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaacop.2026.06.008_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13229-018-0190-z","article-title":"Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)","volume":"9","author":"Stivaros","year":"2018","journal-title":"Mol Autism"},{"issue":"1","key":"10.1016\/j.jaacop.2026.06.008_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.b.32280","article-title":"Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1","volume":"168","author":"Plasschaert","year":"2015","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"6","key":"10.1016\/j.jaacop.2026.06.008_bib36","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10803-014-2321-5","article-title":"Autism spectrum disorder profile in neurofibromatosis type I","volume":"45","author":"Garg","year":"2015","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jaacop.2026.06.008_bib37","series-title":"Social Responsiveness Scale. Second Edition (SRS-2","author":"Constantino","year":"2012"},{"issue":"10","key":"10.1016\/j.jaacop.2026.06.008_bib38","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1007\/s10803-012-1719-1","article-title":"Standardizing ADOS domain scores: separating severity of social affect and restricted and repetitive behaviors","volume":"44","author":"Hus","year":"2014","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"10.1016\/j.jaacop.2026.06.008_bib39","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10803-008-0674-3","article-title":"Standardizing ADOS scores for a measure of severity in autism spectrum disorders","volume":"39","author":"Gotham","year":"2009","journal-title":"J Autism Dev Disord"},{"issue":"8","key":"10.1016\/j.jaacop.2026.06.008_bib40","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s10803-014-2080-3","article-title":"The autism diagnostic observation schedule, module 4: revised algorithm and standardized severity scores","volume":"44","author":"Hus","year":"2014","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"10.1016\/j.jaacop.2026.06.008_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/A:1022602400621","article-title":"The revised Conners\u2019 Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity","volume":"26","author":"Conners","year":"1998","journal-title":"J Abnorm Child Psychol"},{"key":"10.1016\/j.jaacop.2026.06.008_bib42","series-title":"Conners 3rd edition: Manual: Multi-Health Systems","author":"Conners","year":"2008"},{"key":"10.1016\/j.jaacop.2026.06.008_bib43","series-title":"Manual for the ASEBA School-Age Forms & Profiles","author":"Achenbach","year":"2001"},{"key":"10.1016\/j.jaacop.2026.06.008_bib44","series-title":"Manual for the ASEBA Preschool Forms & Profiles","author":"Achenbach","year":"2000"},{"issue":"4","key":"10.1016\/j.jaacop.2026.06.008_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cge.12187","article-title":"A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands","volume":"85","author":"van Minkelen","year":"2014","journal-title":"Clin Genet"},{"issue":"32","key":"10.1016\/j.jaacop.2026.06.008_bib46","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1038\/sj.onc.1210261","article-title":"Tumor microenvironment and neurofibromatosis type I: connecting the GAPs","volume":"26","author":"Le","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jaacop.2026.06.008_bib47","series-title":"R: A Language and Environment for Statistical Computing","year":"2013"},{"key":"10.1016\/j.jaacop.2026.06.008_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"issue":"1","key":"10.1016\/j.jaacop.2026.06.008_bib50","first-page":"310","article-title":"Finding optimal normalizing transformations via bestnormalize","volume":"13","author":"Peterson","year":"2021","journal-title":"R Journal"},{"issue":"3","key":"10.1016\/j.jaacop.2026.06.008_bib51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajmg.a.30346","article-title":"Intelligence in individuals with a neurofibromatosis type 1 microdeletion","volume":"131","author":"Descheemaeker","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"9","key":"10.1016\/j.jaacop.2026.06.008_bib52","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jmg.2009.075937","article-title":"Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions","volume":"47","author":"Mautner","year":"2010","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.jaacop.2026.06.008_bib53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1212\/WNL.0000000000002118","article-title":"Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1","volume":"86","author":"Van Der Vaart","year":"2016","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jaacop.2026.06.008_bib54","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41398-017-0046-x","article-title":"Childhood behaviour problems show the greatest gap between DNA-based and twin heritability","volume":"7","author":"Cheesman","year":"2017","journal-title":"Transl Psychiatry"},{"issue":"5","key":"10.1016\/j.jaacop.2026.06.008_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208960120","article-title":"Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization","volume":"120","author":"Young","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.jaacop.2026.06.008_bib56","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41594-021-00687-2","article-title":"The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1","volume":"28","author":"Lupton","year":"2021","journal-title":"Nat Struct Mol Biol"},{"issue":"6871","key":"10.1016\/j.jaacop.2026.06.008_bib57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.jaacop.2026.06.008_bib58","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr Biol"},{"issue":"3","key":"10.1016\/j.jaacop.2026.06.008_bib59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jaacop.2026.06.008_bib60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.stemcr.2020.03.007","article-title":"Human iPSC-derived neurons and cerebral organoids establish differential effects of germline NF1 gene mutations","volume":"14","author":"Anastasaki","year":"2020","journal-title":"Stem Cell Rep"},{"issue":"11","key":"10.1016\/j.jaacop.2026.06.008_bib61","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/mp.2015.48","article-title":"HCN channels are a novel therapeutic target for cognitive dysfunction in neurofibromatosis type 1","volume":"20","author":"Omrani","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.jaacop.2026.06.008_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nn792","article-title":"Neurofibromin regulates G protein\u2013stimulated adenylyl cyclase activity","volume":"5","author":"Tong","year":"2002","journal-title":"Nat Neurosci"},{"issue":"12","key":"10.1016\/j.jaacop.2026.06.008_bib63","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1093\/hmg\/ddv103","article-title":"Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning","volume":"24","author":"Anastasaki","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.jaacop.2026.06.008_bib64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.23793","article-title":"Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice","volume":"73","author":"Diggs-Andrews","year":"2013","journal-title":"Ann Neurol"},{"issue":"22","key":"10.1016\/j.jaacop.2026.06.008_bib65","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddq382","article-title":"Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice","volume":"19","author":"Brown","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.jaacop.2026.06.008_bib66","article-title":"Functional Assays combined with pre-mRNA-splicing analysis improve variant classification and diagnostics for individuals with neurofibromatosis type 1 and Legius syndrome","volume":"2023","author":"Douben","year":"2023","journal-title":"Hum Mutat"},{"issue":"12","key":"10.1016\/j.jaacop.2026.06.008_bib67","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/humu.24487","article-title":"High-yield identification of pathogenic NF1 variants by skin fibroblast transcriptome screening after apparently normal diagnostic DNA testing","volume":"43","author":"Douben","year":"2022","journal-title":"Hum Mutat"}],"container-title":["JAACAP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949732926000724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949732926000724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:11:52Z","timestamp":1790802712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949732926000724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2949732926000724"],"URL":"https:\/\/doi.org\/10.1016\/j.jaacop.2026.06.008","relation":{},"ISSN":["2949-7329"],"issn-type":[{"value":"2949-7329","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relation Between Genotype and Behavioral Phenotype in Children and Adolescents With Neurofibromatosis Type 1","name":"articletitle","label":"Article Title"},{"value":"JAACAP Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaacop.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Academy of Child & Adolescent Psychiatry.","name":"copyright","label":"Copyright"}]}}